for the treatment for thyroid eye disease (TED). ACELYRIN recently completed a positive end of Phase 2 (EOP2) interaction with the U.S. Food and Drug Administration (FDA), achieving alignment on ...
Arjun Kapoor opened up about living with Hashimoto’s disease, a common yet often overlooked autoimmune condition that can impact quality of life if untreated ...
They are developing medicines and APIs manufactured in individual and combination doses for the treatment of hypercalcemia associated with thyroid tumors and other illnesses ... USA FDA priority ...